Egg Medical Gains Patent Advantage After Rampart Appeal Ends
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
GALWAY, Ireland, June 3, 2026 Medtronic has announced a series of major regulatory and clinical milestones aimed at significantly...
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
WALNUT CREEK, CA, USA & SUZHOU, CHINA, April 27, 2026 Dark Horse Consulting Group (DHCG) and Porton Advanced have...
Walnut Creek, California & Tokyo, Japan, April 21, 2026 In a strategic move to strengthen its global consulting footprint...
